Stock Earnings

Question 1

Urogen Pharma Ltdの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Urogen Pharma Ltdの総資産は$285で、純lossは$-126です。

Question 2

URGNの主要な財務比率は何ですか？

Accepted Answer

Urogen Pharma Ltdの流動比率は0.96、純利益率は-140、1株当たり売上高は$2.09です。

Question 3

Urogen Pharma Ltdの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Urogen Pharma Ltd largest revenue segment is RTGel Reverse Thermal Hydrogel, at a revenue of 90,398,000 in the most earnings release.For geography, Israel is the primary market for Urogen Pharma Ltd, at a revenue of 90,398,000.

Question 4

Urogen Pharma Ltdは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Urogen Pharma Ltdの純lossは$-126です。

Question 5

Urogen Pharma Ltdに負債はありますか？

Accepted Answer

yes、Urogen Pharma Ltdの負債は294です。

Question 6

Urogen Pharma Ltdの発行済株式数は何株ですか？

Accepted Answer

Urogen Pharma Ltdの総発行済株式数は42.23株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	94	90	82	64	48	11
Revenue Growth (YoY)	11%	10%	28%	33%	336%	--
Cost of Revenue	10	8	9	7	5	1
Gross Profit	83	81	73	56	42	10
Selling, General & Admin	141	121	93	82	87	90
Research & Development	65	57	45	52	47	47
Operating Expenses	206	178	138	135	135	137
Other Non Operating Income (Expenses)	-21	-23	-20	-21	-17	0
Pretax Income	-150	-124	-98	-108	-109	-125
Income Tax Expense	4	2	3	1	1	3
Net Income	-154	-126	-102	-109	-110	-128
Net Income Growth	36%	24%	-6%	-1%	-14%	22%
Shares Outstanding (Diluted)	47.73	42.87	28.83	22.81	22.35	21.78
Shares Change (YoY)	30%	49%	26%	2%	3%	6%
EPS (Diluted)	-3.24	-2.95	-3.54	-4.81	-4.96	-5.9
EPS Growth	5%	-17%	-26%	-3%	-16%	15%
Free Cash Flow	-123	-97	-76	-87	-85	-107
Free Cash Flow Per Share	-2.57	-2.26	-2.63	-3.81	-3.8	-4.91
Gross Margin	88.29%	90%	89.02%	87.5%	87.5%	90.9%
Operating Margin	-130.85%	-106.66%	-79.26%	-123.43%	-191.66%	-1,145.45%
Profit Margin	-163.82%	-140%	-124.39%	-170.31%	-229.16%	-1,163.63%
Free Cash Flow Margin	-130.85%	-107.77%	-92.68%	-135.93%	-177.08%	-972.72%
EBITDA	-123	-96	-65	-79	-92	-126
EBITDA Margin	-130.85%	-106.66%	-79.26%	-123.43%	-191.66%	-1,145.45%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-123	-96	-65	-79	-92	-126
EBIT Margin	-130.85%	-106.66%	-79.26%	-123.43%	-191.66%	-1,145.45%
Effective Tax Rate	-2.66%	-1.61%	-3.06%	-0.92%	-0.91%	-2.4%

Urogen Pharma Ltd (URGN) Price

URGN Stock Price Chart

URGN Income

Follow-Up Questions